Randomised clinical trial of the effects of Total Intravenous Anaesthesia (TIVA: propofol) versus volatile anaesthesia (sevoflurane-nitrous oxide) on children's post-operative cognition, behaviour and physical morbidity

ISRCTN ISRCTN33376683
DOI https://doi.org/10.1186/ISRCTN33376683
Protocol serial number CZH/4/382
Sponsor NHS Glasgow and Clyde/University of Glasgow
Funder Chief Scientist Office of the Scottish Executive Health Department (UK) (Grant ref: CZH/4/382)
Submission date
12/03/2007
Registration date
30/04/2007
Last edited
18/04/2016
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Oral Health
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Prof Keith Millar
Scientific

Section of Psychological Medicine
University of Glasgow
Gartnavel Royal Hospital
1055 Great Western Road
Glasgow
G12 0XH
United Kingdom

Phone +44 (0)141 211 3939
Email k.millar@clinmed.gla.ac.uk

Study information

Primary study designInterventional
Study designRandomised single centre clinical trial
Secondary study designRandomised controlled trial
Scientific titleRandomised clinical trial of the effects of Total Intravenous Anaesthesia (TIVA: propofol) versus volatile anaesthesia (sevoflurane-nitrous oxide) on children's post-operative cognition, behaviour and physical morbidity
Study objectivesRecovery of children's cognitive function will be quicker, and physical morbidity less, after intravenous compared to volatile anaesthesia.
Ethics approval(s)West Ethics Committee of the Western Infirmary, 09/01/2007, ref: 07S07033
Health condition(s) or problem(s) studiedDental caries
InterventionChildren will be randomised to separate groups having general anaesthesia with the intravenous agent propofol, or the volatile agent sevoflurane-nitrous oxide. They will perform child-appropriate tests of reaction time, motor control, attention and memory pre-operatively (baseline), post-operatively prior to discharge, and 48 hours later at home.

Between-group comparisons of performance and of post-operative physical morbidity will test the hypothesis stated above.
Intervention typeDrug
PhaseNot Applicable
Drug / device / biological / vaccine name(s)Sevoflurane-nitrous oxide and propofol
Primary outcome measure(s)

Cognitive performance on tests of reaction time, motor control, attention and memory.

Key secondary outcome measure(s)

Physical morbidity assessed by day-surgery staff using a standard protocol at discharge.

Completion date28/02/2010

Eligibility

Participant type(s)Patient
Age groupChild
Lower age limit7 Years
Upper age limit12 Years
SexAll
Target sample size at registration360
Key inclusion criteria1. Male and female children aged seven to 12 years
2. American Society of Anaesthesiologists (ASA) grade I or II
3. Requiring general anaesthesia for multiple dental extractions
Key exclusion criteria1. Respiratory disorder
2. Learning disability
3. Non-fluent English
4. Neurological or psychological impairments that would impede cognitive assessment
Date of first enrolment19/03/2007
Date of final enrolment28/02/2010

Locations

Countries of recruitment

  • United Kingdom
  • Scotland

Study participating centre

Section of Psychological Medicine
Glasgow
G12 0XH
United Kingdom

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
IPD sharing plan

Editorial Notes

18/04/2016: No publications found, verifying study status with principal investigator